Listen to The Lancet Respiratory Medicine

Dr. Mona Bafadhel discusses the STOIC trial, which looked at the use of inhaled budesonide in the treatment of early COVID-19.

Dr. Arvinder Soin discusses the use of tocilizumab plus standard care versus standard care alone in the treatment of moderate to severe COVID-19-associated cytokine release syndrome.

Jordan Feld discusses the use of peginterferon-lambda in the treatment of ambulatory COVID-19 patients.

Rishi Gupta discusses a model to evaluate and predict the risk of clinical deterioration in patients with acute COVID-19

Toby Maher discusses the results of the SENSCIS trial, looking at the safety and efficacy of nintedanib in systemic sclerosis-associated interstitial lung disease (SSc-ILD) treated with mycophenolate.

Dr. Catherine Quantin discusses a new study looking at the ways severe influenza and COVID-19 are similar and differ.

Dan Lewer of University College London discusses a modelling study that looks at housing strategies for homeless populations in the UK during COVID-19.

Dr. Anna Schultze discusses inhaled corticosteroid use in COPD and asthma patients and whether they have either a protective or harmful effect when related to COVID-19

Richard Beasley discusses a Series of three papers in The Lancet and The Lancet Respiratory Medicine that consider the promise of novel strategies to drive down the global burden of asthma.

Dr. Reagan-Steiner and Dr. Gary about pathlogical findings in suspected cases of e-cigarette, or vaping, product use-associated lung injury, or EVALI.

Dr. Tina Hartert discusses a new study that aimed to evaluate the strength for a causal effect of Respiratory Syncytial Virus-Lower Respiratory Tract Infection (RSV-LRTI) in subsequent chronic wheezing illness to inform public health expectations for RSV vaccines.

Authors of a new population-based study on the association between antibiotic use in infancy and risk of asthma later in life discuss the results of their trial and how they might influence paediatricians and parents.

David Maslove and Daniel E. Leisman discuss their recent paper published in Critical Care Medicine discussing guidance on the development of prediction models for critical care

Don Sin discusses a new tool for clinicians to use to detect potential exacerbations in patients with chronic obstructive pulmonary disorder.

Authors of the MERGE Trial discuss treatment of mild obstructive sleep apnea and the effectiveness of continuous positive airway pressure, or CPAP, in the treatment of patients with mild OSA

Authors from a new case series talk about the development of an algorithm they developed for the diagnosis and treatment of e-cigarette or vaping product use-associated lung injury, or EVALI.

Dr. Marcelo Cypel discusses a trial looking at lung transplantation from Hepatitis C viremic donors.

Dr Scott Bell and Dr Felix Ratjen discuss The Lancet Respiratory Medicine 's Cystic Fibrosis Commission on the future of cystic fibrosis care.

Dr. Luca Richeldi discusses a trial looking at pamrevlumab, an anti-connective tissue growth factor therapy for the treatment of idiopathic pulmonary fibrosi

Dr. Natalie Walker discusses a trial she and her colleagues conducted looking at the effectiveness of nicotine patches used in conjunction with e-cigarettes for smoking cessation.

Grant Theron discusses growing evidence of the importance of the lung and gut microbiomes in tuberculosis, and how this knowledge might affect the future of treatment. 

Dr Vikas Goyal discuses the use of oral antibiotic treatment in non-severe exacerbations of bronchiectasis in children.

Dr Gabriel Loor discusses a new study looking at how the normothermic portable Organ Care System works to improve donor lungs for transplantation.

Alex Franciosi talks with The Lancet Respiratory Medicine about the pitfalls and caveats of testing for α1-antitrypsin deficiency.

Thushan de Silva, from the Medical Research Council Unit in The Gambia, discusses a new study looking at the immunogenicity of live-attenuated influenza vaccines among children in The Gambia.